LiY., YuZ., LiuF., TanL., WuB., LiJ.: Oral glutamine ameliorates chemotherapy-induced changes of intestinal permeability and does not interfere with the antitumor effect of chemotherapy in patients with breast cancer: a prospective randomized trial.Tumori, 92: 396–401, 2006.
2.
MelicharB., UrbanekL., KrcmovaL., KalabovaH., SvobodovaI., DragounovaE., VeselyP., HysplerR., SolichovaD.: Urinary neopterin in patients with ovarian cancer.Pteridines, 17: 145–153, 2006.
3.
HerzogT.J.: Recurrent ovarian cancer: how important is it to treat disease progression?Clin Cancer Res,10: 7439–7449, 2004.
4.
MelicharB., DvorakJ., HysplerR., ZadakZ.: Intestinal permeability in the assessment of intestinal toxicity of cytotoxic agents.Chemotherapy, 51: 336–338, 2005.
5.
SukkarS.G., SchenoneE., FoppianiL., NobileT.: Experimental assessment of chemotherapy-induced early intestinal damage in colon cancer the lactulose-mannitol permeability test.Tumori, 90: 461–463, 2004.
